Benitec Biopharma Inc. Common Stock

Go to Benitec Biopharma Inc. Common Stock Website

$11.53

-0.09 (-0.82%)
Live
Previous Close

$11.525

Day Range

$11.3 - $11.74

Previous Day Range

$11.05 - $11.7358

Market Cap

$305.0 million USD

Day Vol.

45702

Previous Day Vol.

58799

Currency

USD

Primary Exchange

Nasdaq

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treat...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Benitec Biopharma announced the acceptance of a late-breaking oral abstract for the BB-301 Phase 1b/2a clinical study in Oculopharyngeal Muscular Dystrophy (OPMD) patients. Interim clinical study updates for the first three subjects will be presented at the Muscular Dystrophy Association Clinical and Scientific Conference in March 2025.

Related tickers: BNTC.

Read Full Article

The global RNA-based therapeutic market is expected to grow from $9.46 billion in 2025 to $40.81 billion by 2034, driven by the rising prevalence of genetic disorders and the demand for personalized medicine. North America and Asia Pacific are the key regional markets.

Related tickers: IONS, ALNY, BNTC, SLN, XLO.

Read Full Article
Trending Tickers

Please sign in to view